SCHEMBL4675568

SCHEMBL4675568

O=C(O)C(O)=CC(=O)c1cc(Cc2ccccc2)c[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
PKM P14618 1/20 0.37
DAO P14920 2/20 0.36
PLA2G10 O15496 1/20 0.36
PLA2G2A P14555 1/20 0.36
LMNA P02545 1/20 0.36
HNF4A P41235 1/20 0.36
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 1/20 0.35
MEN1 O00255 1/20 0.35
CALM1 P0DP23 1/20 0.35
PTPN1 P18031 2/20 0.34
PTPN2 P17706 1/20 0.34
PTPN6 P29350 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
HRH1 P35367 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB2 P47870 1/20 0.34
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4675566 1.00 GAA (0.39) GAARAB9APKMDAOPLA2G10
SCHEMBL4675875 0.87 DAO (0.37) PKMDAOLMNAKMT2AALDH1A1
SCHEMBL4673973 0.87 MAPK7 (0.38) DAOLMNAALDH1A1GABRA1GABRB2
SCHEMBL4675216 0.87 SRD5A2 (0.40) PKMDAOLMNAKMT2AALDH1A1
SCHEMBL4675213 0.87 SRD5A2 (0.40) PKMDAOLMNAKMT2AALDH1A1
SCHEMBL4670509 0.87 ALDH1A1 (0.38) DAOPLA2G10PLA2G2AALDH1A1
SCHEMBL4673970 0.87 MAPK7 (0.38) DAOLMNAALDH1A1GABRA1GABRB2
SCHEMBL4675878 0.87 DAO (0.37) PKMDAOLMNAKMT2AALDH1A1
SCHEMBL4670512 0.87 ALDH1A1 (0.38) DAOPLA2G10PLA2G2AALDH1A1
SCHEMBL4678232 0.87 HCAR2 (0.41) DAOHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
CN-1335834-A Aromatic heterocyclic compounds having HIV integrase inhibitory activity SHIONOGI & CO (JP) 2002-02-13 CN disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 GAA 1884/4885RAB9A 2021/4885PKM 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.